BIVDA Press Releases

19Mar

BIVDA Board elects Darren Stenlake as Chair

Darren Stenlake (Sysmex UK Ltd), has been elected as Chairman of the BIVDA Board effective March 14, 2019, for a three-year term. The position, held by Simon Richards (Abbott Rapid Diagnostics) during 2016-19, will continue to represent BIVDA’s mission and vision to all stakeholders.

Doris-Ann Williams, Chief Executive of BIVDA said: “We are delighted to welcome Darren Stenlake as our new Chair. Darren’s insight as well as vast knowledge of diagnostics and the sector’s landscape will both maximise value for our membership and provide guidance for BIVDA’s strategy over the next three years.”

Darren Stenlake said: “I look forward to building on the excellent work achieved by Simon and the Board and to continue raising awareness of this incredibly innovative sector and the key role it serves in influencing and improving health outcomes. The diagnostics sector is going through a phase of unprecedented change, supporting and guiding our members through this change continues to be a key focal area for BIVDA.”

In addition to Darren fulfilling the Board Chair position, Richard Hames (Werfen Ltd) has been elected as member of the Board through to 2022. Jag Grewal (Omega Diagnostics Group plc) and Chris Hudson (Roche Diagnostics) have also been re-elected to the BIVDA Board.

About BIVDA

BIVDA is the national industry association for the manufacturers and distributors of IVD products in the UK. We currently represent more than 95% of the industry and over a hundred organisations ranging from British start up companies to UK subsidiaries of multinational corporations.

BIVDA members currently employ over 8,500 people in the UK, with a total industry turnover of approximately £920 million.

Related

PwC analysis highlights economic footprint of UK Life Sciences

The productivity of the UK’s Life Sciences sector is more than double the UK average, says a new re...

Read More >

BIVDA Launches IVD Value Story

The British In Vitro Diagnostics Association (BIVDA) has today (25 October) launched its new report ...

Read More >

BIVDA responds to the final report of the Accelerated Access Review

Doris-Ann Williams MBE, Chief Executive of BIVDA, has responded to the publication of the final repo...

Read More >

Government Responds to AAR Report – BIVDA’s View

The Government has today (04 November) published its response to the final report of the Accelerated...

Read More >

BIVDA Celebrates Milestone 25th Anniversary

The British In Vitro Diagnostics Association (BIVDA) celebrated its milestone 25th Anniversary on Mo...

Read More >

BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer

BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commis...

Read More >